Literature DB >> 23298802

Differentiating arthritic from myofascial pain in children with juvenile idiopathic arthritis: preliminary report.

Shelly Abramowicz1, Susan Kim, Harlyn K Susarla, Leonard B Kaban.   

Abstract

PURPOSE: To differentiate between temporomandibular joint (TMJ) inflammation and myofascial pain (MPD) in children with juvenile idiopathic arthritis (JIA). PATIENTS AND METHODS: We performed a retrospective study of children with JIA evaluated at Boston Children's Hospital, Boston, Massachusetts. Patients, aged 16 years or younger at the time of diagnosis, were included if they had confirmed JIA with jaw signs or symptoms. Medical records and imaging studies were reviewed to document demographic, clinical, and radiographic findings. Patients with clinical evidence (joint pain/tenderness, asymmetry, limited motion) and radiographic evidence (condylar asymmetry, flattening, accentuated antegonial notch) of TMJ inflammation but without muscle pain were diagnosed with arthritis. Those with only muscle tenderness and/or limited jaw motion were diagnosed with MPD. Patients with TMJ inflammation and muscle pain/tenderness were considered to have co-existing arthritis and MPD. Outcome variables were the presence of TMJ arthritis and/or MPD. Descriptive statistics were computed.
RESULTS: There were 61 patients (44 girls) with a mean age of 12.7 years (range, 3 to 16 years) who met the inclusion criteria. The most common clinical findings were limited mouth opening (n = 24), malocclusion/asymmetry (n = 23), and/or tenderness to palpation (n = 18). Twenty-one patients had multiple signs and symptoms. Panoramic radiographs showed condylar abnormalities in 32 patients. Overall, 21 patients (34.4%) were diagnosed with active TMJ arthritis, 21 (34.4%) with MPD, and 11 (18%) with both arthritis and MPD. Of the patients, 8 (13.1%) were in remission.
CONCLUSIONS: The results of this study indicate that in patients with JIA and jaw signs/symptoms, there is an overlap in diagnoses between arthritis and MPD. This has considerable implications for patient management.
Copyright © 2013 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23298802     DOI: 10.1016/j.joms.2012.10.027

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  5 in total

1.  Management of inflammatory temporomandibular joint collapse in children.

Authors:  Daili Diaz; Baruch Goldberg; Shelly Abramowicz
Journal:  J Oral Biol Craniofac Res       Date:  2021-02-27

2.  Contrast-enhanced MRI compared to direct joint visualization at arthroscopy in pediatric patients with suspected temporomandibular joint synovitis.

Authors:  Jessica R Leschied; Ethan A Smith; Scott Baker; Shokoufeh Khalatbari; Sharon Aronovich
Journal:  Pediatr Radiol       Date:  2018-10-31

3.  Orofacial pain in juvenile idiopathic arthritis is associated with stress as well as psychosocial and functional limitations.

Authors:  Alexandra Dimitrijevic Carlsson; Kerstin Wahlund; Erik Kindgren; Thomas Skogh; Carin Starkhammar Johansson; Per Alstergren
Journal:  Pediatr Rheumatol Online J       Date:  2019-12-19       Impact factor: 3.054

4.  Is early TMJ involvement in children with juvenile idiopathic arthritis clinically detectable? Clinical examination of the TMJ in comparison with contrast enhanced MRI in patients with juvenile idiopathic arthritis.

Authors:  Heidi Keller; Lukas Markus Müller; Goran Markic; Thomas Schraner; Christian Johannes Kellenberger; Rotraud Katharina Saurenmann
Journal:  Pediatr Rheumatol Online J       Date:  2015-12-09       Impact factor: 3.054

5.  Quantifying Temporomandibular Joint Synovitis in Children With Juvenile Idiopathic Arthritis.

Authors:  Cory M Resnick; Pouya M Vakilian; Micheál Breen; David Zurakowski; Paul Caruso; Lauren Henderson; Peter A Nigrovic; Leonard B Kaban; Zachary S Peacock
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-12       Impact factor: 4.794

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.